Universe Pharmaceuticals earnings were -$18.5M for the trailing 12 months ending Mar 31, 2024, with N/A growth year over year. The latest UPC earnings report on Mar 31, 2024 announced Q1 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2023 ending Sep 30, 2023, UPC reported annual earnings of -$6.2M, with -29.5% growth.
Universe Pharmaceuticals Earnings Reports & History FAQ
What were Universe Pharmaceuticals's earnings last quarter?
Universe Pharmaceuticals (NASDAQ: UPC) reported Q1 2024 earnings per share (EPS) of N/A, up N/A year over year. Total UPC earnings for the quarter were N/A. In the same quarter last year, Universe Pharmaceuticals's earnings per share (EPS) was N/A.
Is Universe Pharmaceuticals profitable or losing money?
As of the last Universe Pharmaceuticals earnings report, Universe Pharmaceuticals is currently losing money. Universe Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2024 was -$18.55 million, a 65.86% increase year over year.
What was UPC's earnings growth in the past year?
As of Universe Pharmaceuticals's earnings date in Q2 2025, Universe Pharmaceuticals's earnings has grown year over year. UPC earnings in the past year totalled -$18.55 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.